BCM
ACAD icon

Bodri Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bodri Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300,000
Closed -$9.53M – 46
2014
Q4 		$9.53M Hold
300,000
– – 4.38% 5
2014
Q3 		$7.43M Buy
300,000
+175,000
+140% +$4.09M 3.6% 6
2014
Q2 		$2.82M Sell
125,000
-75,000
-38% -$1.57M 1.46% 25
2014
Q1 		$4.87M Buy
200,000
+25,000
+14% +$632K 2.47% 14
2013
Q4 		$4.37M Buy
175,000
+25,000
+17% +$590K 2.12% 17
2013
Q3 		$4.12M Buy
150,000
+50,000
+50% +$1.05M 2.4% 16
2013
Q2 		$1.81M Buy
+100,000
New +$1.38M 1.12% 35

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return